Our report describes a critical case of clinically amyopathic dermatomyositis (CADM) with RP-ILD that tested positive for both anti-MDA5 and anti-Ro-52 antibodies. The gene discussed is IFIH1; the disease is clinically amyopathic dermatomyositis.